4/18/2013

In vitro diagnostic products would not be subject to centralized or decentralized premarket approval under a draft report released by the European Parliament on IVD regulation in Europe. Rather, the report calls for improving the system for notified bodies and reinforcing the market oversight and vigilance program, among other recommendations.

Related Summaries